240 related articles for article (PubMed ID: 15212862)
1. The cerivastatin withdrawal crisis: a "post-mortem" analysis.
Maggini M; Raschetti R; Traversa G; Bianchi C; Caffari B; Da Cas R; Panei P
Health Policy; 2004 Aug; 69(2):151-7. PubMed ID: 15212862
[TBL] [Abstract][Full Text] [Related]
2. [Withdrawal of cerivastatin revealed a flaw of post-marketing surveillance system in the United States].
Saito M; Hirata-Koizumi M; Miyake S; Hasegawa R
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2005; (123):41-5. PubMed ID: 16541751
[TBL] [Abstract][Full Text] [Related]
3. Estimating the extent of reporting to FDA: a case study of statin-associated rhabdomyolysis.
McAdams M; Staffa J; Dal Pan G
Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):229-39. PubMed ID: 18175291
[TBL] [Abstract][Full Text] [Related]
4. Rhabdomyolysis associated with hydroxymethylglutaryl-coenzyme A reductase inhibitors.
Jamal SM; Eisenberg MJ; Christopoulos S
Am Heart J; 2004 Jun; 147(6):956-65. PubMed ID: 15199341
[TBL] [Abstract][Full Text] [Related]
5. Effects of cerivastatin withdrawal on statin persistence.
Reaume KT; Erickson SR; Dorsch MP; Dunham NL; Hiniker SM; Prabhakar N; Kline-Rogers EM; Eagle KA
Ann Pharmacother; 2008 Jul; 42(7):956-61. PubMed ID: 18523235
[TBL] [Abstract][Full Text] [Related]
6. Failure to continue lipid-lowering drug use following the withdrawal of cerivastatin.
Mantel-Teeuwisse AK; Klungel OH; Egberts TC; Verschuren WM; Porsius AJ; de Boer A
Drug Saf; 2004; 27(1):63-70. PubMed ID: 14720086
[TBL] [Abstract][Full Text] [Related]
7. [Rhabdomyolysis following cerivastatin monotherapy--implications for therapy with HMG-CoA reductase inhibitors].
Sparing R; Sellhaus B; Noth J; Block F
Nervenarzt; 2003 Feb; 74(2):167-71. PubMed ID: 12596018
[TBL] [Abstract][Full Text] [Related]
8. Rhabdomyolysis with HMG-CoA reductase inhibitors and gemfibrozil combination therapy.
Chang JT; Staffa JA; Parks M; Green L
Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):417-26. PubMed ID: 15269925
[TBL] [Abstract][Full Text] [Related]
9. A case with severe rhabdomyolysis and renal failure associated with cerivastatin-gemfibrozil combination therapy--a case report.
Ozdemir O; Boran M; Gökçe V; Uzun Y; Koçak B; Korkmaz S
Angiology; 2000 Aug; 51(8):695-7. PubMed ID: 10959522
[TBL] [Abstract][Full Text] [Related]
10. Rhabdomyolysis from the combination of a statin and gemfibrozil: an uncommon but serious adverse reaction.
Kind AH; Zakowski LJ; McBride PE
WMJ; 2002; 101(7):53-6. PubMed ID: 12426921
[TBL] [Abstract][Full Text] [Related]
11. [Myopathy with rhabdomyolysis as an adverse effect of simultaneous treatment with cerivastatin and gemfibrozil].
Huić M; Anić B; Cikes N; Bosnić D; Sentić M; Markeljević J; Mayer M; Pazanin L
Lijec Vjesn; 2002; 124(3-4):73-6. PubMed ID: 18956824
[TBL] [Abstract][Full Text] [Related]
12. [Rhabdomyolysis and anuric kidney failure induced by the treatment with a gemfibrozil-cerivastatin combination].
Sirvent AE; Cabezuelo JB; Enríquez R; Amorós F; González C; Reyes A
Nefrologia; 2001; 21(5):497-500. PubMed ID: 11795020
[TBL] [Abstract][Full Text] [Related]
13. [Myotoxicity and rhabdomyolisis due to statins].
Banga JD
Ned Tijdschr Geneeskd; 2001 Dec; 145(49):2371-6. PubMed ID: 11770264
[TBL] [Abstract][Full Text] [Related]
14. Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients.
Nichols GA; Koro CE
Clin Ther; 2007 Aug; 29(8):1761-70. PubMed ID: 17919557
[TBL] [Abstract][Full Text] [Related]
15. Case reports of rhabdomyolysis associated with cerivastatin therapy.
Simpson S
Arch Intern Med; 2001 Nov; 161(21):2630-1. PubMed ID: 11718617
[No Abstract] [Full Text] [Related]
16. Other reports of cerivastatin-induced rhabdomyolysis.
Gabay M; Lodolce A
Arch Intern Med; 2001 Nov; 161(21):2629. PubMed ID: 11718614
[No Abstract] [Full Text] [Related]
17. Potential for conflict of interest in the evaluation of suspected adverse drug reactions: use of cerivastatin and risk of rhabdomyolysis.
Psaty BM; Furberg CD; Ray WA; Weiss NS
JAMA; 2004 Dec; 292(21):2622-31. PubMed ID: 15572720
[TBL] [Abstract][Full Text] [Related]
18. Another report of acute rhabdomyolysis following cerivastatin monotherapy.
Milionis HJ; Tsapoga TG; Elisaf MS
Arch Intern Med; 2001 Nov; 161(21):2629-30. PubMed ID: 11718615
[No Abstract] [Full Text] [Related]
19. Rhabdomyolysis associated with cerivastatin plus gemfibrozil combined regimen.
Marsà Carretero M; Alos Manrique C; Valles Callol JA
Br J Gen Pract; 2002 Mar; 52(476):235-6. PubMed ID: 12030671
[No Abstract] [Full Text] [Related]
20. Risk factors for statin-associated rhabdomyolysis.
Schech S; Graham D; Staffa J; Andrade SE; La Grenade L; Burgess M; Blough D; Stergachis A; Chan KA; Platt R; Shatin D
Pharmacoepidemiol Drug Saf; 2007 Mar; 16(3):352-8. PubMed ID: 16892458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
